These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31212824)

  • 1. Systematic Analysis of the Service Process and the Legislative and Regulatory Environment for a Pharmacist-Provided Naltrexone Injection Service in Wisconsin.
    Ford JH; Gilson A; Mott DA
    Pharmacy (Basel); 2019 Jun; 7(2):. PubMed ID: 31212824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacy-based injectable naltrexone service delivery models and best practices.
    Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
    Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot testing a tool to determine the costs and time associated with community pharmacy-based administration of injectable naltrexone.
    Ford JH; Gilson AM; Bryan GM; Gicquelais RE; Gassman M; Mott DA
    Res Social Adm Pharm; 2022 Jul; 18(7):3210-3215. PubMed ID: 34728163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Pharmacist in Combating the Opioid Crisis: An Update.
    Kosobuski L; O'Donnell C; Koh-Knox Sharp CP; Chen N; Palombi L
    Subst Abuse Rehabil; 2022; 13():127-138. PubMed ID: 36597518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring barriers and facilitators to pharmacist-provided diabetes self-management education and support.
    Gawlik G; Nguyen E; Robinson R
    J Am Pharm Assoc (2003); 2023; 63(1):74-79. PubMed ID: 36114100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
    Gargya D; Mirkazemi C; Curtain C
    J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of community pharmacist administration of long-acting injectable antipsychotic medications.
    Black RM; Hughes TD; Ma F; Hudzik AA; Shepherd G; Ferreri S; Ozawa S
    J Am Pharm Assoc (2003); 2023; 63(3):742-750.e3. PubMed ID: 36740528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding state laws and a growing role for pharmacists in vaccination services.
    Schmit CD; Penn MS
    J Am Pharm Assoc (2003); 2017; 57(6):661-669. PubMed ID: 28807659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice.
    Punekar Y; Lin SW; Thomas J
    J Am Pharm Assoc (2003); 2003; 43(4):503-10. PubMed ID: 12952315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study.
    Meijvis VAM; Heringa M; Kwint HF; de Wit NJ; Bouvy ML
    Int J Clin Pharm; 2023 Aug; 45(4):970-979. PubMed ID: 37253951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacists' perceptions of the barriers and facilitators to the implementation of paediatric clinical pharmacy services in Hong Kong.
    Sin CM; Huynh C; Maidment ID
    Int J Pharm Pract; 2022 Nov; 30(5):466-471. PubMed ID: 35900004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.